Modern Pathology

Papers
(The TQCC of Modern Pathology is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-07-01 to 2024-07-01.)
ArticleCitations
COVID-19 pulmonary pathology: a multi-institutional autopsy cohort from Italy and New York City361
A systematic review of pathological findings in COVID-19: a pathophysiological timeline and possible mechanisms of disease progression343
In situ detection of SARS-CoV-2 in lungs and airways of patients with COVID-19248
Digital pathology and artificial intelligence in translational medicine and clinical practice222
SARS-CoV-2 can infect the placenta and is not associated with specific placental histopathology: a series of 19 placentas from COVID-19-positive mothers200
Hepatic pathology in patients dying of COVID-19: a series of 40 cases including clinical, histologic, and virologic data178
Pathophysiology of SARS-CoV-2: the Mount Sinai COVID-19 autopsy experience177
New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia144
Classification and reporting guidelines for the pathology diagnosis of placenta accreta spectrum (PAS) disorders: recommendations from an expert panel127
Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia117
Development of a prognostic model for mortality in COVID-19 infection using machine learning113
Novel artificial intelligence system increases the detection of prostate cancer in whole slide images of core needle biopsies113
Validation of a digital pathology system including remote review during the COVID-19 pandemic112
Major p53 immunohistochemical patterns in in situ and invasive squamous cell carcinomas of the vulva and correlation with TP53 mutation status106
Prospective multi-institutional evaluation of pathologist assessment of PD-L1 assays for patient selection in triple negative breast cancer98
Poorly differentiated thyroid carcinoma of childhood and adolescence: a distinct entity characterized by DICER1 mutations97
TRPS1: a highly sensitive and specific marker for breast carcinoma, especially for triple-negative breast cancer95
Artificial intelligence assistance significantly improves Gleason grading of prostate biopsies by pathologists93
Lung neuroendocrine neoplasms: recent progress and persistent challenges90
Factors associated with myocardial SARS-CoV-2 infection, myocarditis, and cardiac inflammation in patients with COVID-1988
Comparison of three PD-L1 immunohistochemical assays in head and neck squamous cell carcinoma (HNSCC)80
Histopathological findings and clinicopathologic correlation in COVID-19: a systematic review79
A pan-cancer analysis of PD-L1 immunohistochemistry and gene amplification, tumor mutation burden and microsatellite instability in 48,782 cases78
DICER1 tumor predisposition syndrome: an evolving story initiated with the pleuropulmonary blastoma76
Quality control stress test for deep learning-based diagnostic model in digital pathology75
Deep learning trained on hematoxylin and eosin tumor region of Interest predicts HER2 status and trastuzumab treatment response in HER2+ breast cancer71
Counting mitoses: SI(ze) matters!71
Prediction of early recurrence of hepatocellular carcinoma after resection using digital pathology images assessed by machine learning68
An independent assessment of an artificial intelligence system for prostate cancer detection shows strong diagnostic accuracy67
Homologous recombination deficiency (HRD) score in germline BRCA2- versus ATM-altered prostate cancer65
NTRK insights: best practices for pathologists65
Comparing programmed death ligand 1 scores for predicting pembrolizumab efficacy in head and neck cancer65
Clinicopathologic and molecular characterization of NTRK-rearranged thyroid carcinoma (NRTC)64
Clinicopathologic features of kinase fusion-related thyroid carcinomas: an integrative analysis with molecular characterization64
Clinicopathological significance of deficient DNA mismatch repair and MLH1 promoter methylation in endometrioid endometrial carcinoma60
Histiocytic hyperplasia with hemophagocytosis and acute alveolar damage in COVID-19 infection59
HER2-low breast cancers: incidence, HER2 staining patterns, clinicopathologic features, MammaPrint and BluePrint genomic profiles58
Mesonephric and mesonephric-like carcinomas of the female genital tract: molecular characterization including cases with mixed histology and matched metastases57
NTRK3 overexpression in undifferentiated sarcomas with YWHAE and BCOR genetic alterations56
ALK rearranged renal cell carcinoma (ALK-RCC): a multi-institutional study of twelve cases with identification of novel partner genes CLIP1, KIF5B and KIAA121756
PD-L1 expression in gastric cancer: interchangeability of 22C3 and 28-8 pharmDx assays for responses to immunotherapy55
Broadening the spectrum of NTRK rearranged mesenchymal tumors and usefulness of pan-TRK immunohistochemistry for identification of NTRK fusions54
Mesenchymal tumors of the gastrointestinal tract with NTRK rearrangements: a clinicopathological, immunophenotypic, and molecular study of eight cases, emphasizing their distinction from gastrointesti52
Integrating digital pathology into clinical practice51
EWSR1/FUS–CREB fusions define a distinctive malignant epithelioid neoplasm with predilection for mesothelial-lined cavities50
Four major patterns of placental injury: a stepwise guide for understanding and implementing the 2016 Amsterdam consensus50
p53 immunohistochemistry in endometrial cancer: clinical and molecular correlates in the PORTEC-3 trial49
Predictors of pathological complete response to neoadjuvant treatment and changes to post-neoadjuvant HER2 status in HER2-positive invasive breast cancer48
Pituitary neuroendocrine tumors: a model for neuroendocrine tumor classification47
Diffuse trophoblast damage is the hallmark of SARS-CoV-2-associated fetal demise47
Effect of decalcification protocols on immunohistochemistry and molecular analyses of bone samples46
Clinicopathological analysis of 34 Japanese patients with EBV-positive mucocutaneous ulcer45
Liver biopsy findings in patients on immune checkpoint inhibitors44
Tumor spread through air spaces (STAS): prognostic significance of grading in non-small cell lung cancer44
Novel uses of immunohistochemistry in breast pathology: interpretation and pitfalls44
Eosinophilic vacuolated tumor (EVT) of kidney demonstrates sporadic TSC/MTOR mutations: next-generation sequencing multi-institutional study of 19 cases43
T-cell clones of uncertain significance are highly prevalent and show close resemblance to T-cell large granular lymphocytic leukemia. Implications for laboratory diagnostics43
Grading of medullary thyroid carcinoma on the basis of tumor necrosis and high mitotic rate is an independent predictor of poor outcome43
The pathogenic role of epithelial and endothelial cells in early-phase COVID-19 pneumonia: victims and partners in crime41
Fibroepithelial lesions revisited: implications for diagnosis and management41
NFATc2-rearranged sarcomas: clinicopathologic, molecular, and cytogenetic study of 7 cases with evidence of AGGRECAN as a novel diagnostic marker40
Genetic and clinical correlates of entosis in pancreatic ductal adenocarcinoma40
DICER1-associated central nervous system sarcoma in children: comprehensive clinicopathologic and genetic analysis of a newly described rare tumor39
Frequent traces of EBV infection in Hodgkin and non-Hodgkin lymphomas classified as EBV-negative by routine methods: expanding the landscape of EBV-related lymphomas39
Molecular characterization of invasive and in situ squamous neoplasia of the vulva and implications for morphologic diagnosis and outcome39
Artificial intelligence-assisted system for precision diagnosis of PD-L1 expression in non-small cell lung cancer39
Biomarkers of response to checkpoint inhibitors beyond PD-L1 in lung cancer39
Molecular characterization of diffuse malignant peritoneal mesothelioma39
Prognostic value of macrophage polarization markers in epithelial neoplasms and melanoma. A systematic review and meta-analysis37
Genomic profiling of primary and recurrent adult granulosa cell tumors of the ovary37
Interpretable multimodal deep learning for real-time pan-tissue pan-disease pathology search on social media37
Genomic landscape of endometrial carcinomas of no specific molecular profile36
Germline and sporadic mTOR pathway mutations in low-grade oncocytic tumor of the kidney36
Cribriform architecture in radical prostatectomies predicts oncological outcome in Gleason score 8 prostate cancer patients36
Deep convolutional neural network-based classification of cancer cells on cytological pleural effusion images35
Novel BRAF gene fusions and activating point mutations in spindle cell sarcomas with histologic overlap with infantile fibrosarcoma34
DEK-AFF2 fusion-associated papillary squamous cell carcinoma of the sinonasal tract: clinicopathologic characterization of seven cases with deceptively bland morphology34
Low-grade oncocytic renal tumor (LOT): mutations in mTOR pathway genes and low expression of FOXI134
Pleural mesothelioma classification—update and challenges34
A machine learning algorithm for simulating immunohistochemistry: development of SOX10 virtual IHC and evaluation on primarily melanocytic neoplasms34
Deep learning prediction of BRAF-RAS gene expression signature identifies noninvasive follicular thyroid neoplasms with papillary-like nuclear features34
Identification of nodal micrometastasis in colorectal cancer using deep learning on annotation-free whole-slide images34
PD-L1 in small bowel adenocarcinoma is associated with etiology and tumor-infiltrating lymphocytes, in addition to microsatellite instability33
Amsterdam International Consensus Meeting: tumor response scoring in the pathology assessment of resected pancreatic cancer after neoadjuvant therapy33
Invasive squamous cell carcinomas and precursor lesions on UV-exposed epithelia demonstrate concordant genomic complexity in driver genes33
YAP1-TFE3-fused hemangioendothelioma: a multi-institutional clinicopathologic study of 24 genetically-confirmed cases32
Genetic characteristics of gastric-type mucinous carcinoma of the uterine cervix32
Prognostic and predictive value of the newly proposed grading system of invasive pulmonary adenocarcinoma in Chinese patients: a retrospective multicohort study31
EWSR1-PATZ1 fusion renal cell carcinoma: a recurrent gene fusion characterizing thyroid-like follicular renal cell carcinoma31
Lipoblastomas presenting in older children and adults: analysis of 22 cases with identification of novel PLAG1 fusion partners31
Diverse immune environments in human lung tuberculosis granulomas assessed by quantitative multiplexed immunofluorescence31
Undifferentiated round cell sarcoma with BCOR internal tandem duplications (ITD) or YWHAE fusions: a clinicopathologic and molecular study30
The mutational landscape of histiocytic sarcoma associated with lymphoid malignancy30
Molecular characterization of chromophobe renal cell carcinoma reveals mTOR pathway alterations in patients with poor outcome30
Clinicopathologic and molecular analysis of embryonal rhabdomyosarcoma of the genitourinary tract: evidence for a distinct DICER1-associated subgroup30
Superficial ALK-rearranged myxoid spindle cell neoplasm: a cutaneous soft tissue tumor with distinctive morphology and immunophenotypic profile30
A new tool for technical standardization of the Ki67 immunohistochemical assay30
Nuclear expression of DDIT3 distinguishes high-grade myxoid liposarcoma from other round cell sarcomas30
Recurrent MEIS1-NCOA2/1 fusions in a subset of low-grade spindle cell sarcomas frequently involving the genitourinary and gynecologic tracts29
“Inflammatory Leiomyosarcoma” and “Histiocyte-rich Rhabdomyoblastic Tumor”: a clinicopathological, immunohistochemical and genetic study of 13 cases, with a proposal for reclassification as “Inflammat29
Novel GATA6-FOXO1 fusions in a subset of epithelioid hemangioma29
Recommendations on compiling test datasets for evaluating artificial intelligence solutions in pathology29
Invasive apocrine carcinoma of the breast: clinicopathologic features and comprehensive genomic profiling of 18 pure triple-negative apocrine carcinomas29
INSM1 expression in a subset of thoracic malignancies and small round cell tumors: rare potential pitfalls for small cell carcinoma29
Assessment of deep learning assistance for the pathological diagnosis of gastric cancer29
TFEB rearranged renal cell carcinoma. A clinicopathologic and molecular study of 13 cases. Tumors harboring MALAT1-TFEB, ACTB-TFEB, and the novel NEAT1-TFEB translocations constantly express PDL128
E-cadherin to P-cadherin switching in lobular breast cancer with tubular elements28
Massively parallel sequencing analysis of 68 gastric-type cervical adenocarcinomas reveals mutations in cell cycle-related genes and potentially targetable mutations28
Melanomas with activating RAF1 fusions: clinical, histopathologic, and molecular profiles28
Prognostic impact of tumor microvessels in intrahepatic cholangiocarcinoma: association with tumor-infiltrating lymphocytes28
Targeted RNA expression profiling identifies high-grade endometrial stromal sarcoma as a clinically relevant molecular subtype of uterine sarcoma28
High-grade transformation of low-grade endometrial stromal sarcomas lacking YWHAE and BCOR genetic abnormalities27
IGF2BP1 is the first positive marker for anaplastic thyroid carcinoma diagnosis27
The healthcare value of the Magee Decision Algorithm™: use of Magee Equations™ and mitosis score to safely forgo molecular testing in breast cancer27
A large-scale internal validation study of unsupervised virtual trichrome staining technologies on nonalcoholic steatohepatitis liver biopsies27
Myxoid pleomorphic liposarcoma—a clinicopathologic, immunohistochemical, molecular genetic and epigenetic study of 12 cases, suggesting a possible relationship with conventional pleomorphic liposarcom27
Histopathologic features and molecular genetic landscape of HER2-amplified endometrial carcinomas27
Epstein–Barr-virus-positive large B-cell lymphoma associated with breast implants: an analysis of eight patients suggesting a possible pathogenetic relationship27
Detection and assessment of capsular invasion, vascular invasion and lymph node metastasis volume in thyroid carcinoma using microCT scanning of paraffin tissue blocks (3D whole block imaging): a proo26
Reproducibility of scoring criteria for HER2 immunohistochemistry in endometrial serous carcinoma: a multi-institutional interobserver agreement study26
Myxoinflammatory fibroblastic sarcoma: an immunohistochemical and molecular genetic study of 73 cases26
Utility of methylthioadenosine phosphorylase immunohistochemical deficiency as a surrogate for CDKN2A homozygous deletion in the assessment of adult-type infiltrating astrocytoma26
EWSR1-PATZ1-rearranged sarcoma: a report of nine cases of spindle and round cell neoplasms with predilection for thoracoabdominal soft tissues and frequent expression of neural and skeletal muscle mar26
Histologic grading of breast carcinoma: a multi-institution study of interobserver variation using virtual microscopy26
Problematic breast tumors reassessed in light of novel molecular data26
Differentiated exophytic vulvar intraepithelial lesion: Clinicopathologic and molecular analysis documenting its relationship with verrucous carcinoma of the vulva26
The clinical behavior and genomic features of the so-called adenoid cystic carcinomas of the solid variant with basaloid features26
Molecular classification of follicular thyroid carcinoma based on TERT promoter mutations25
MIXTURE of human expertise and deep learning—developing an explainable model for predicting pathological diagnosis and survival in patients with interstitial lung disease25
Prognostic impact of tumor budding in endometrial carcinoma within distinct molecular subgroups25
Clinical, morphologic, and genomic findings in ROS1 fusion Spitz neoplasms25
Spatial immunoprofiling of the intratumoral and peritumoral tissue of renal cell carcinoma patients25
Evaluation of glucocorticoid-induced TNF receptor (GITR) expression in breast cancer and across multiple tumor types25
PHF1 fusions cause distinct gene expression and chromatin accessibility profiles in ossifying fibromyxoid tumors and mesenchymal cells25
HPV-independent, p53-wild-type vulvar intraepithelial neoplasia: a review of nomenclature and the journey to characterize verruciform and acanthotic precursor lesions of the vulva25
MicroRNA signatures associated with lymph node metastasis in intramucosal gastric cancer25
B7-H3 immune checkpoint expression is a poor prognostic factor in colorectal carcinoma25
Papillary neoplasms of the breast—reviewing the spectrum25
NUTM1-rearranged colorectal sarcoma: a clinicopathologically and genetically distinctive malignant neoplasm with a poor prognosis24
Prediction of non-muscle invasive bladder cancer recurrence using machine learning of quantitative nuclear features24
Clinical and molecular validation of BAP1, MTAP, P53, and Merlin immunohistochemistry in diagnosis of pleural mesothelioma24
Pleuropulmonary blastoma-like peritoneal sarcoma: a newly described malignancy associated with biallelic DICER1 pathogenic variation24
Homologous Recombination Repair Deficiency: An Overview for Pathologists24
The genetics of ductal adenocarcinoma of the pancreas in the year 2020: dramatic progress, but far to go24
Comparison of solid tissue sequencing and liquid biopsy accuracy in identification of clinically relevant gene mutations and rearrangements in lung adenocarcinomas24
TP53 mutations and CDKN2A mutations/deletions are highly recurrent molecular alterations in the malignant progression of sinonasal papillomas24
Deep learning-based histotype diagnosis of ovarian carcinoma whole-slide pathology images24
ARID1A mutations and expression loss in non-small cell lung carcinomas: clinicopathologic and molecular analysis24
Molecular landscape of IDH-mutant primary astrocytoma Grade IV/glioblastomas23
A prognostic score for non-small cell lung cancer resected after neoadjuvant therapy in comparison with the tumor-node-metastases classification and major pathological response23
Myeloid/lymphoid neoplasms with FLT3 rearrangement23
Myositis ossificans-like soft tissue aneurysmal bone cyst: a clinical, radiological, and pathological study of seven cases with COL1A1-USP6 fusion and a novel ANGPTL2-USP6 fusion23
Prospective molecular classification of endometrial carcinomas: institutional implementation, practice, and clinical experience23
A novel prognostic two-gene signature for triple negative breast cancer23
Analysis of the immune checkpoint V-domain Ig-containing suppressor of T-cell activation (VISTA) in endometrial cancer23
Systematically higher Ki67 scores on core biopsy samples compared to corresponding resection specimen in breast cancer: a multi-operator and multi-institutional study23
Recurrent novel HMGA2-NCOR2 fusions characterize a subset of keratin-positive giant cell-rich soft tissue tumors23
An unusual phenotype occurs in 15% of mismatch repair-deficient tumors and is associated with non-colorectal cancers and genetic syndromes23
Testosterone therapy and breast histopathological features in transgender individuals23
Tumor-infiltrating lymphocytes are associated with poor prognosis in invasive lobular breast carcinoma23
Clinical and pathologic features associated with PD-L1 (SP142) expression in stromal tumor-infiltrating immune cells of triple-negative breast carcinoma23
Ki-67 assessment of pancreatic neuroendocrine neoplasms: Systematic review and meta-analysis of manual vs. digital pathology scoring23
Triple-negative breast lobular carcinoma: a luminal androgen receptor carcinoma with specific ESRRA mutations23
Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses22
Loss of expression of YAP1 C-terminus as an ancillary marker for epithelioid hemangioendothelioma variant with YAP1-TFE3 fusion and other YAP1-related vascular neoplasms22
Minimalist approaches to cancer tissue-of-origin classification by DNA methylation22
The Role of Artificial Intelligence in Accurate Interpretation of HER2 Immunohistochemical Scores 0 and 1+ in Breast Cancer22
Artificial neural networks and pathologists recognize basal cell carcinomas based on different histological patterns22
Pan-sarcoma genomic analysis of KMT2A rearrangements reveals distinct subtypes defined by YAP1–KMT2A–YAP1 and VIM–KMT2A fusions22
Refined diagnosis of hydatidiform moles with p57 immunohistochemistry and molecular genotyping: updated analysis of a prospective series of 2217 cases22
Receptor conversion in metastatic breast cancer: analysis of 390 cases from a single institution22
Lung-only melanoma: UV mutational signature supports origin from occult cutaneous primaries and argues against the concept of primary pulmonary melanoma21
Diffuse expression of MUC6 defines a distinct clinicopathological subset of pulmonary invasive mucinous adenocarcinoma21
Next-generation sequencing reveals heterogeneous genetic alterations in key signaling pathways of mismatch repair deficient colorectal carcinomas21
Clinicopathological and genomic characterization of BCORL1-driven high-grade endometrial stromal sarcomas21
Endogenous APOBEC3B overexpression characterizes HPV-positive and HPV-negative oral epithelial dysplasias and head and neck cancers21
Embryonal rhabdomyosarcoma of the uterine corpus: a clinicopathological and molecular analysis of 21 cases highlighting a frequent association with DICER1 mutations21
Chromosomal and molecular pathway alterations in the neuroendocrine carcinoma and adenocarcinoma components of gastric mixed neuroendocrine–nonneuroendocrine neoplasm21
Fusion partners of NTRK3 affect subcellular localization of the fusion kinase and cytomorphology of melanocytes21
Activation of the RAS pathway through uncommon BRAF mutations in mucinous pancreatic cysts without KRAS mutation21
Prognostic value of desmoplastic stroma in intrahepatic cholangiocarcinoma21
TSC loss is a clonal event in eosinophilic solid and cystic renal cell carcinoma: a multiregional tumor sampling study21
Genotyping diagnosis of gestational trophoblastic disease: frontiers in precision medicine21
Immunohistochemical detection of PAX-FOXO1 fusion proteins in alveolar rhabdomyosarcoma using breakpoint specific monoclonal antibodies21
The histologic presentation of hepatitis E reflects patients' immune status and pre-existing liver condition21
Multi-institutional Assessment of Pathologist Scoring HER2 Immunohistochemistry21
RAF1 rearrangements are common in pancreatic acinar cell carcinomas20
DICER1-associated sarcomas: towards a unified nomenclature20
Hypersensitivity pneumonitis: new concepts and classifications20
Do we need an updated classification of oncocytic renal tumors?20
p53 Immunohistochemical patterns in HPV-related neoplasms of the female lower genital tract can be mistaken for TP53 null or missense mutational patterns20
Clonal relationship and directionality of progression of synchronous endometrial and ovarian carcinomas in patients with DNA mismatch repair-deficiency associated syndromes20
Molecular landscape of vulvovaginal squamous cell carcinoma: new insights into molecular mechanisms of HPV-associated and HPV-independent squamous cell carcinoma20
Nodal cytotoxic peripheral T-cell lymphoma occurs frequently in the clinical setting of immunodysregulation and is associated with recurrent epigenetic alterations20
Nodular fasciitis: a comprehensive, time-correlated investigation of 17 cases20
Intratumoral budding and automated CD8-positive T-cell density in pretreatment biopsies can predict response to neoadjuvant therapy in rectal adenocarcinoma20
Association of artificial intelligence-powered and manual quantification of programmed death-ligand 1 (PD-L1) expression with outcomes in patients treated with nivolumab ± ipilimumab20
KRAS amplification in metastatic colon cancer is associated with a history of inflammatory bowel disease and may confer resistance to anti-EGFR therapy20
Heterozygous/dispermic complete mole confers a significantly higher risk for post-molar gestational trophoblastic disease20
Characterization of TP53-wildtype tubo-ovarian high-grade serous carcinomas: rare exceptions to the binary classification of ovarian serous carcinoma20
Oncocytic renal neoplasms with diffuse keratin 7 immunohistochemistry harbor frequent alterations in the mammalian target of rapamycin pathway19
Direct identification of ALK and ROS1 fusions in non-small cell lung cancer from hematoxylin and eosin-stained slides using deep learning algorithms19
Calcified chondroid mesenchymal neoplasms with FN1-receptor tyrosine kinase gene fusions including FGFR2, FGFR1, MERTK, NTRK1, and TEK: a molecular and clinicopathologic analysis19
Clinicopathological and genomic features in patients with head and neck neuroendocrine carcinoma19
Intimal sarcomas and undifferentiated cardiac sarcomas carry mutually exclusive MDM2, MDM4, and CDK6 amplifications and share a common DNA methylation signature19
Malignant peritoneal mesothelioma: prognostic significance of clinical and pathologic parameters and validation of a nuclear-grading system in a multi-institutional series of 225 cases19
Assessment of the feasibility of frozen sections for the detection of spread through air spaces (STAS) in pulmonary adenocarcinoma19
Breast cancer with neuroendocrine differentiation: an update based on the latest WHO classification19
Histological regression in melanoma: impact on sentinel lymph node status and survival19
Expanding the clinicopathological spectrum of succinate dehydrogenase-deficient renal cell carcinoma with a focus on variant morphologies: a study of 62 new tumors in 59 patients19
Multi-magnification-based machine learning as an ancillary tool for the pathologic assessment of shaved margins for breast carcinoma lumpectomy specimens19
Adult NTRK-rearranged spindle cell neoplasms of the viscera: with an emphasis on rare locations and heterologous elements18
Grade and Estrogen Receptor Expression Identify a Subset of No Specific Molecular Profile Endometrial Carcinomas at a Very Low Risk of Disease-Specific Death18
Genetic differences between benign phyllodes tumors and fibroadenomas revealed through targeted next generation sequencing18
Genomic profiling of pleomorphic and florid lobular carcinoma in situ reveals highly recurrent ERBB2 and ERRB3 alterations18
Identification of novel SSX1 fusions in synovial sarcoma18
Detecting mismatch repair deficiency in solid neoplasms: immunohistochemistry, microsatellite instability, or both?18
Genomic evidence suggests that cutaneous neuroendocrine carcinomas can arise from squamous dysplastic precursors18
A novel next generation sequencing approach to improve sarcoma diagnosis18
The clinicopathologic spectrum and genomic landscape of de-/trans-differentiated melanoma18
Well differentiated papillary mesothelial tumor: a new name and new problems18
TRIM63 is a sensitive and specific biomarker for MiT family aberration-associated renal cell carcinoma18
Prediction of malignant transformation and recurrence of oral epithelial dysplasia using architectural and cytological feature specific prognostic models18
TERT promoter mutation is an objective clinical marker for disease progression in chondrosarcoma18
Nuclear expression of AFF2 C-terminus is a sensitive and specific ancillary marker for DEK::AFF2 carcinoma of the sinonasal tract18
Hybrid schwannoma–perineurioma frequently harbors VGLL3 rearrangement18
Genetic profiling and biomarkers in peripheral T-cell lymphomas: current role in the diagnostic work-up18
Associations of non-pedunculated T1 colorectal adenocarcinoma outcome with consensus molecular subtypes, immunoscore, and microsatellite status: a multicenter case-cohort study18
Comparative molecular analysis of testicular Leydig cell tumors demonstrates distinct subsets of neoplasms with aggressive histopathologic features17
Recurrent KRAS mutations are early events in the development of papillary renal neoplasm with reverse polarity17
High Interobserver Variability Among Pathologists Using Combined Positive Score to Evaluate PD-L1 Expression in Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma17
Tumour infiltrating lymphocyte status is superior to histological grade, DNA mismatch repair and BRAF mutation for prognosis of colorectal adenocarcinomas with mucinous differentiation17
Melanoma with in-frame deletion of MAP2K1: a distinct molecular subtype of cutaneous melanoma mutually exclusive from BRAF, NRAS, and NF1 mutations17
PD-L1 expression, tumor-infiltrating lymphocytes, mismatch repair deficiency, EGFR alteration and HPV infection in sinonasal squamous cell carcinoma17
Clinico-pathologic predictors of patterns of residual disease following neoadjuvant chemotherapy for breast cancer17
Quantitative comparison of PD-L1 IHC assays against NIST standard reference material 193417
Computer-Assisted Diagnosis of Lymph Node Metastases in Colorectal Cancers Using Transfer Learning With an Ensemble Model17
Adenoid ameloblastoma harbors beta-catenin mutations17
Updates in grading and invasion assessment in lung adenocarcinoma17
Histopathologic features of breast cancer in Li–Fraumeni syndrome17
Interobserver variability in the assessment of stromal tumor-infiltrating lymphocytes (sTILs) in triple-negative invasive breast carcinoma influences the association with pathological complete respons17
Artificial intelligence for advance requesting of immunohistochemistry in diagnostically uncertain prostate biopsies17
Uterine PEComas: correlation between melanocytic marker expression and TSC alterations/TFE3 fusions17
EWSR1-WT1 gene fusions in neoplasms other than desmoplastic small round cell tumor: a report of three unusual tumors involving the female genital tract and review of the literature17
Integrating artificial intelligence in pathology: a qualitative interview study of users' experiences and expectations17
Clinicopathologic characterization of malignant chondroblastoma: a neoplasm with locally aggressive behavior and metastatic potential that closely mimics chondroblastoma-like osteosarcoma17
Molecular and clinicopathologic characterization of intravenous leiomyomatosis17
Pancreatic ductal adenocarcinomas associated with intraductal papillary mucinous neoplasms (IPMNs) versus pseudo-IPMNs: relative frequency, clinicopathologic characteristics and differential diagnosis16
The histologic diagnosis of usual interstitial pneumonia of idiopathic pulmonary fibrosis. Where we are and where we need to go16
MHC class I loss in endometrial carcinoma: a potential resistance mechanism to immune checkpoint inhibition16
0.051178932189941